COLOMBO, CARLA
COLOMBO, CARLA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
The impact of vitamin D status on lipid profiles and atherogenic dyslipidemia markers in children and adolescents with obesity
2024 V. Calcaterra, V. Fabiano, A. De Silvestri, C. Colombo, V. Tranfaglia, M. Loiodice, D. Ceruti, G. Zuccotti
Poorly differentiated thyroid carcinoma: molecular, clinico-pathological hallmarks and therapeutic perspectives
2024 V. Cirello, C. Gambale, A.V. Nikitski, C. Masaki, J. Roque, C. Colombo
Vitamin D levels and lipid profile in children and adolescents: a tight correlation
2024 D. Ceruti, C. Colombo, M. Loiodice, S. DE LEO, V. Calcaterra, V. Fabiano
Hypocalcemia During Lenvatinib Treatment for Advanced Thyroid Cancer: Clinical Features and Management in a Real-Life Setting
2023 S. De Leo, M. Trevisan, C. Colombo, C. Moneta, N. Giancola, L. Fugazzola
Inactivating mutations of TP53 and resistence to tyrosine-kinase inhibitors in patients affected with aggressive thyroid cancer
2023 V. Cirello, C. Colombo, A. Manzo, D. Tosi, U. Gianelli, G. Gazzano, S. Ferrero, L. Persani, L. Fugazzola
Targeting the DNA damage response kinase Chk1 in TP53-mutated aggressive thyroid cancers: in vitro studies
2023 A. Manzo, V. Cirello, E.S. Grassi, C. Colombo, L. Fugazzola, L. Persani
Targeting the DNA damage response kinase CHK1 in TP53-mutated thyroid cancer: in vitro studies
2023 A. Manzo, V. Cirello, E.S. Grassi, C. Colombo, L. Fugazzola, L. Persani
Management of hypertension during Lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm
2023 C. Colombo, D. Ceruti, S. DE LEO, G. Bilo, M. Trevisan, N. Giancola, C. Moneta, G. Parati, L. Persani, L. Fugazzola
Letter to the Editor: Tumor Lysis Syndrome During Selpercatinib Treatment in a Patient with Medullary Thyroid Cancer
2023 S. De Leo, M. Trevisan, G.V. Re Sartò, C. Moneta, M. Pirovano, C. Colombo, L. Cosmai, L. Fugazzola
Endocrine-related adverse conditions induced by tyrosine kinase inhibitors.
2023 S. De Leo, M. Trevisan, C. Moneta, C. Colombo
Polycystic ovary syndrome and thyroid disorder: a comprehensive narrative review of the literature
2023 S. Palomba, C. Colombo, A. Busnelli, D. Caserta, G. Vitale
Lenvatinib-induced hypocalcaemia due to transient primary hypoparathyroidism
2022 M. Trevisan, C. Colombo, N. Giancola, C. Moneta, G. Dionigi, L. Fugazzola, S. De Leo
Thyroid cancer harboring PTEN and TP53 mutations: A peculiar molecular and clinical case report
2022 C. Colombo, G. Pogliaghi, D. Tosi, M. Muzza, G. Bulfamante, L. Persani, L. Fugazzola, V. Cirello
Small Bowel Neuroendocrine Tumors: Focus on Pathologic Aspects and Controversial Surgical Issues
2022 A. Pino, F. Frattini, A. Ieni, C. Colombo, S. De Leo, S. Rausei, L. Boni, G. Lianos, G. Fadda, K. Yub, S. Baldari, A. Campenni, G. Dionigi
Daily Management of Patients on Multikinase Inhibitors' Treatment
2022 C. Colombo, S. De Leo, M. Trevisan, N. Giancola, A. Scaltrito, L. Fugazzola
FAM83B is involved in thyroid cancer cell differentiation and migration
2022 V. Cirello, E. Grassi, G. Pogliaghi, V. Ghiandai, L. Ermellino, M. Muzza, G. Gazzano, L. Persani, C. Colombo, L. Fugazzola
Unilateral Surgery for Medullary Thyroid Carcinoma: Seeking for Clinical Practice Guidelines
2022 D. Zhang, C. Colombo, H. Sun, H.Y. Kim, A. Pino, S. De Leo, G. Gazzano, L. Persani, G. Dionigi, L. Fugazzola
Persistent Thyroid Carcinoma and Pregnancy: Outcomes in an Italian Series and Review of the Literature
2022 C. Colombo, S. De Leo, N. Giancola, M. Trevisan, D. Ceruti, F. Frattini, L. Persani, L. Fugazzola
Oxidative Stress Correlates with More Aggressive Features in Thyroid Cancer
2022 M. Muzza, G. Pogliaghi, C. Colombo, E. Carbone, V. Cirello, S. Palazzo, F. Frattini, D. Gentilini, G. Gazzano, L. Persani, L. Fugazzola
Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers
2021 V. Cirello, C. Colombo, O. Karapanou, G. Pogliaghi, L. Persani, L. Fugazzola